Blog

  1. The Veterinary Cancer Center Joins Compassion-First Pet Hospitals

    NORWALK, CT – July 20, 2016 –The Veterinary Cancer Center (The VCC) of Norwalk, Connecticut, announced today, it is merged with the Compassion-First Pet Hospitals family of well-known veterinary hospitals.

    Located at 129 Glover Ave, in Norwalk, The VCC was founded in 1998 by Gerald Post, DVM, MEM, DACVIM (Oncology) and is the only specialized veterinary practice dedicated to the diagnosis and treatment of cancer in animals.

    “As the only standalone veterinary hospital solely dedicated to treating cancer in animals, we are constantly seeking new alternatives to treat cancer says Dr. Gerald Post. “We have entered an age where consumer demands on medical advancements is growing. To meet these demands, we needed a partner like Compassion-First Pet Hospitals to help us take the critical next step forward to advance oncology care. Unlike veterinary consolidator Compassion First focuses on quality of medicine, client service and hospital culture first and foremost; allowing us to focus on being the best veterinary cancer center in the world.”

    Founded in 2014, Compassion-First is a collaborative family of hospitals that retain their equity, uniqueness, integrity and medical decisions. With Compassion-First, hospitals gain the benefit of working together, maximizing their resources, and are united by a common passion to put pet owners and their pets at the center of care.

    “The VCC’s commitment to advancing oncology treatment through chemotherapy, radiation therapy, immunotherapy and surgery should be established as a model of care.” Says John Payne, CEO of Compassion-First. “Our hope is to assist them in sharing their expertise with the profession. We are absolutely thrilled to have them join our family of hospitals.”

    Dr. Gerlad Post and David Duchemin, COO will continue to lead the medical and operational needs of The Veterinary Cancer Center. For more information, please visit http://theveterinarycancercenter.com

    About Compassion-First Pet Hospitals

    Compassion-First Pet Hospitals is a family of well-known and respected general, emergency and specialty veterinary hospitals across the United States. Founded in 2014 by John Payne, Compassion-First Pet Hospitals is comprised of hospitals, working together through collaboration to advance veterinary medicine and increase access to multidisciplinary expertise. Compassion-First Hospitals focuses on placing pet owners and their pets at the center of care. For a list of Compassion-First Pet Hospitals, visit www.compassionfirstpets.com.

  2. Our 3rd Annual ACF Veterinary Challenge!

    Our 3rd Annual ACF Veterinary Challenge will be taking place at Chelsea Piers – CT in Stamford, CT. on Sunday, October 25, 2015.  The invitation time will be 1:30 pm for team check – in, the competition takes place from 2 – 4 pm, and the reception will be scheduled from 4 to 5 pm.  The event is great fun and I’d like to have as many of you as possible attending that day.  Please mark your calendars now!

    For you who are new, the ACF Veterinary Challenge is a friendly competition for veterinary hospital teams comprised of doctors, techs and support staff.  Hospitals donate $300 to ACF for the privilege of sending 5 team members to the games.  Games are fun, friendly team building style events.  This year we will likely have trampoline dodgeball, rock wall climbing, and a variety of challenge games taking place on the basketball courts, but no necessarily basketball.  Past events have included using team skills to stack apples, untie human knots, negotiate mazes, etc. etc. etc.  Teams win prizes for 1st, 2nd and 3rd but also for best costumes, team spirit, etc.

    Here is the URL to the community page for the event on Facebook.  Please like this page if you haven’t done so already.  If you know vets and vet techs in the Westchester and Fairfield County, CT area, please send them the link or share our posts with them.  Let’s create some buzz!!!

    https://www.facebook.com/ACFVeterinaryChallenge?ref=hl

    The Veterinary Cancer Center and IDEXX Laboratories will be returning as premier sponsors for 2015.  IDEXX is also lending ACF manpower support by having their CT rep and their Westchester rep help us promote the event at all the area veterinary hospitals.  Space is limited so sign up now! (click here to sign up)

    For information please contact Steven Bonell or Jerrald Williams at 2013-838-6626.

  3. The Future of Veterinary Medicine – Here Today!

    Dear Friends and Colleagues,

    I hope this letter finds all of you well. I am excited to introduce our new company, Innogenics. We are a diagnostic company offering genomic based testing for companion animals. I am the Chief Medical Officer and the rest of our executive team brings the needed experience in veterinary pathology, comparative oncology, business development and marketing needed to make Innogenics successful. Our first product, available now, is our Enlight Assay ®. This test will give you the gene expression patterns of 30 canine genes that are important to all veterinarians who diagnose and treat cancer.

    This information will allow you to give your clients more accurate information about diagnosis, prognosis and therapy. Gene expression and mutation analysis has become exceedingly important in human medicine, particularly in the field of oncology. Unfortunately genomic testing in companion animals has been impeded by a number of challenges. Innogenics has developed an automated, robust, reproducible, and cost-effective assay that uses small amounts of formalin-fixed paraffin embedded (FFPE) samples prepared on glass slides.

    One of the key features of our technology is that your workflow remains unchanged. You can still submit your surgical biopsy samples to your laboratory of choice. If the diagnosis is cancer, you simply send Innogenics one H & E stained slide and 5 unstained slides.

    Innogenics is proud to introduce an affordably priced molecular approach to companion animal diagnostics and therapeutics that has substantial advantages over current practices. We all know how expensive (and unreliable) multiple immunohistochemical (IHC) stains are and how much time is wasted waiting for results.  Because our technology works reliably on FFPE specimens and our results are rapid, Innogenics will save you time and your client’s money.

    Innogenics is the company that will bring personalized cancer therapy to veterinarians by providing comprehensive, sensitive and accurate cancer genome analysis in ‘real-time’.

    If you would like any more information or to find out how to submit samples to us, please visit our web site www.innogenics.org.

    Thank you,

    Dr. Gerald S. Post

    The Veterinary Cancer Center

    http://www.vcchope.com/about/staff/dr-gerald-post